Characteristics of the study groups in project financed by National Science Center (NCN- Narodowe Cenrtrum Nauki); 2021/41/B/NZ5/00305; 15-oxo-eicosatetraenoic acid (15-oxo-ETE) as a potential diagnostic biomarker of aspirin-exacerbated respiratory disease.

<p><span style="color:rgb( 0 , 0 , 0 )">The file &#34;Characteristics of the study groups&#34; from a National Science Center (NCN) project (2021/41/B/NZ5/00305) includes demographic and clinical data of patients studied for 15-oxo-eicosatetraenoic acid (15-oxo-ETE) as a potential biomarker for aspirin-exacerbated respiratory disease (AERD). The data covers patient demographics, smoking history (pack-years), disease severity (GINA 2021), treatment details, and number of exacerbations in the past year. Patients are categorized as AERD or aspirin-tolerant asthma (ATA). This overview supports assessment of 15-oxo-ETE across different patient profiles.</span></p>